Dr. Eric Dean Merrill, MD

Dr. Merrill practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Merrill's NPI, 1689161952, was assigned on April 21, 2018. Dr. Merrill graduated from UMKC School of Medicine in 2016. Dr. Merrill's California license number on file is A166305.

Dr. Merrill's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Merrill's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Merrill to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merrill practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Merrill's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Merrill is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Merrill's licenses on file in 2 states: California and District of Columbia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, rash, scalp rash and skin cyst among the conditions Dr. Merrill treats.

CMS data shows 471 Medicare services from Dr. Merrill across 9 procedure codes in 2024, for 116 Medicare patients. Medicare paid $18,330 for them. Every service was in an office.

CMS counts 116 Medicare patients who saw Dr. Merrill in 2024. The largest group is 65 to 74, with 51 patients. 72% of them have high cholesterol, and 63% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merrill's median patient age at 67, with 47% women.

In 2024, Dr. Merrill wrote 332 Medicare Part D claims for 68 patients. 91% of them were for generic drugs. CMS names the drug for 252 of them, across 8 drugs with 11 or more claims each, at $56,202 in total drug cost. In 2023, CMS named 138 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Merrill for performance year 2024, reported as part of a group. Dr. Merrill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Merrill as offering telehealth. CMS counts 167 procedures of removal of skin lesions by Dr. Merrill, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Merrill, published from 2015 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Atherosclerosis, Drug Eruptions and Skin. Dr. Merrill's most frequent co-authors are Geetha Raghuveer, MD, Erin Huiras Amerson, MD and Ryan Y. Arakaki, MD.

CMS Open Payments shows 6 general payments to Dr. Merrill from 3 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $96.

Dr. Merrill graduated from UMKC School of Medicine in 2016.

Dr. Merrill is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.